[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349773-105":59,"doc-detail-349773-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","deciphering-the-regulatory-landscape-of-enhancer-rnas-in-health-and-disease","Deciphering the regulatory landscape of enhancer RNAs in health and disease","","Enhancers are distal cis-regulatory elements that coordinate spatiotemporal gene expression, and genetic or epigenetic disruptions can drive disease, especially cancer. Active enhancers produce enhancer RNAs (eRNAs), which integrate into complex gene regulatory networks through multiple mechanisms. Dysregulated eRNA expression is reported across cancer types and is linked to patient survival. This review summarizes eRNA biology, mechanisms, diagnostic and prognostic relevance, and therapeutic potential, including current strategies and key challenges for targeting eRNAs.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deciphering-the-regulatory-landscape-of-enhancer-rnas-in-health-and-disease/349773/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deciphering-the-regulatory-landscape-of-enhancer-rnas-in-health-and-disease/349773.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What are enhancer RNAs (eRNAs) and where are they produced?","Question",{"text":113,"@type":114},"eRNAs are nascent RNA transcripts broadly transcribed from active enhancer regions. They arise from enhancer activity associated with gene regulation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are enhancers and eRNAs linked to cancer?",{"text":118,"@type":114},"Genetic and epigenetic alterations in enhancers can initiate and promote human diseases, including cancers. Dysregulated eRNA expression has been reported across cancer types and correlates with patient survival outcomes.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic potential do eRNAs offer?",{"text":122,"@type":114},"eRNAs are emerging as promising biomarkers and therapeutic targets. The review discusses strategies for targeting RNA transcripts, including eRNAs, and major challenges in developing eRNA-targeted therapies.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349773,1790242011,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Signal Transduction [and Targeted Therapy](and Targeted Therapy www.nature.com/sigtrans)[ www.nature.com/sigtrans](and Targeted Therapy www.nature.com/sigtrans)  \nREVIEW ARTICLE OPEN  \nDeciphering the regulatory landscape of enhancer RNAs in health and disease  \nQian Wang1 ✉, Peter ten Dijke1 ✉ and Chuannan Fan 1 ✉  \n\n|  | Enhancers are distal cis-regulatory elements that orchestrate spatiotemporal gene expression patterns in response to developmental cues and environmental stimuli. Genetic and epigenetic alterations in enhancers are associated with the initiation and progression of human diseases, including cancers. Over the past few decades, accumulating evidence has revealed that a class of nascent RNA transcripts, known as enhancer RNAs (eRNAs), is broadly transcribed from active enhancers. These eRNA species contribute to complex and dynamic gene regulatory networks under both physiological and pathological conditions through diverse mechanisms. Notably, dysregulated eRNA expression has been reported across various cancer types and is often correlated with patient survival outcomes. Consequently, eRNAs are emerging as promising biomarkers and therapeutic targets for cancer treatment. This review provides a comprehensive summary of the current understanding of eRNAs and their mechanisms of action in gene regulation. We discuss the critical roles of eRNAs in both health and disease and highlight their diagnostic and prognostic value, as well as their therapeutic potential in cancer. Additionally, we review current strategies for targeting RNA transcripts, including eRNAs, and discuss the major challenges in developing eRNA-targeted therapies. Finally, we propose future directions for |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| advancing eRNA-based interventions in the treatment of human diseases, including cancer. |  |  |\n|  | Signal Transduction and Targeted Therapy (2026)11:29 ; [https://doi.org/10.1038/s41392-025-02436-z](https://doi.org/10.1038/s41392-025-02436-z) |  |\n|  |  |  |\n\nINTRODUCTION  \nGene transcription is a highly dynamic and tightly controlled process.1,2 Despite sharing an identical set of genetic material, cells establish diverse gene expression patterns in response to developmental, environmental, and intrinsic cellular signals.2,3 This process is primarily regulated through the precise binding of transcription factors (TFs) to speciﬁc DNA sequences, collectively known as transcriptional regulatory elements (TREs), which include promoters, enhancers, and silencers.4–6 Promoters are DNA sequences that serve as primary docking sites for RNA polymerase and TFs to initiate gene transcription.2,7–10 Typically, promoters are positioned upstream of the transcription start site (TSS) of their target genes and often contain conserved sequence motifs, such as the TATA box, initiator elements, and CpG islands.9, 11 Unlike promoters, enhancers are often located distal to their target genes but regulate transcription by facilitating chromatin looping or recruiting cofactors to interact with promoters.12, 13 The coordinated interplay between these elements ensures the precise spatiotemporal control of gene expression. Disruptions in this regulatory network can lead to aberrant gene expression, contributing to developmental disorders and diseases such as cancer.14–16  \nAdvancements in high-throughput sequencing and powerful clustered regularly interspaced short palindromic repeats (CRISPR)-Cas-based gene and RNA editing techniques have made it feasible to gain deeper insights into the human genome, facilitating the discovery of a wide variety of novel RNA transcriptsand a comprehensive characterization of their functions.17–19 Among these RNA species, enhancer RNAs (eRNAs), transcribed  \nfrom active enhancer regions, play a critical role in activating target genes through modulating the functions of their corresponding enhancer","cbCaiq4vByNzfJU0","https://ap.wps.com/l/cbCaiq4vByNzfJU0","pdf",4611571,25,"English","# Introduction\n# Enhancers and gene regulation\n# Enhancer RNAs (eRNAs): biogenesis, regulation, and detection\n# Roles of eRNAs in health and disease\n# Targeting eRNAs for therapy\n# Challenges and future directions","[{\"question\":\"What are enhancer RNAs (eRNAs) and where are they produced?\",\"answer\":\"eRNAs are nascent RNA transcripts broadly transcribed from active enhancer regions. They arise from enhancer activity associated with gene regulation.\"},{\"question\":\"How are enhancers and eRNAs linked to cancer?\",\"answer\":\"Genetic and epigenetic alterations in enhancers can initiate and promote human diseases, including cancers. Dysregulated eRNA expression has been reported across cancer types and correlates with patient survival outcomes.\"},{\"question\":\"What therapeutic potential do eRNAs offer?\",\"answer\":\"eRNAs are emerging as promising biomarkers and therapeutic targets. The review discusses strategies for targeting RNA transcripts, including eRNAs, and major challenges in developing eRNA-targeted therapies.\"}]","Deciphering the regulatory landscape of enhancer RNAs in health and disease | PDF",1790085478,63,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddc008abe78ad095bfbea7ba1f5a3fad.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8789d01dc26ca5ff3127d1781b7ad077.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85741e1b3de2fbed72e30f0ed6b4a1d4.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d1cfe52864296d8db8f9a65ac12f8c00.webp",980,1301]